Mode of action of hypomethylating agents for MDS
Panobinostat and donor lymphocyte infusions in patients with high-risk AML and MDS
The drugs being used to treat newly diagnosed AML patients
How to treat difficult forms of MDS
Bispecific agents: the future of AML and MDS treatment?